Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 13 | $47,651,976 |
Sells | 7 | $333,524 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
19 Mar 2025 18:11 | SLRN | ACELYRIN Inc | KIM MINA | Chief Executive Officer | 17 Mar 2025 | Sale | 17,986 | 2.744 | 49,354 | D |
19 Mar 2025 18:06 | SLRN | ACELYRIN Inc | MURUGAN AMAR | Chief Legal Officer | 17 Mar 2025 | Sale | 3,913 | 2.744 | 10,737 | D |
19 Mar 2025 17:55 | SLRN | ACELYRIN Inc | MPOFU SHEPHARD | Chief Medical Officer | 17 Mar 2025 | Sale | 3,211 | 2.744 | 8,811 | D |
19 Jul 2024 18:18 | SLRN | ACELYRIN Inc | BECKER DANIEL J. | Director | 17 Jul 2024 | Sale | 1 | 6.86 | 7 | D |
03 Apr 2024 18:18 | SLRN | ACELYRIN Inc | LIN SHAO-LEE | Chief Executive Officer | 01 Apr 2024 | Sale | 9,961 | 6.6283 | 66,024 | D |
22 Feb 2024 19:04 | SLRN | ACELYRIN Inc | LIN SHAO-LEE | Chief Executive Officer | 20 Feb 2024 | Sale | 15,701 | 7.6048 | 119,403 | D |
04 Jan 2024 18:09 | SLRN | ACELYRIN Inc | LIN SHAO-LEE | Chief Executive Officer | 02 Jan 2024 | Sale | 10,691 | 7.407 | 79,188 | D |
11 May 2023 21:16 | SLRN | ACELYRIN Inc | WESTLAKE BIOPARTNERS FUND II, L.P. | 10% | 09 May 2023 | Purchase | 1,250,000 | 18 | 22,500,000 | D |
11 May 2023 21:13 | SLRN | ACELYRIN Inc | SEIDENBERG BETH C | Director , 10% | 09 May 2023 | Purchase | 60,000 | 18 | 1,080,000 | D |
11 May 2023 21:13 | SLRN | ACELYRIN Inc | SEIDENBERG BETH C | Director , 10% | 09 May 2023 | Purchase | 1,250,000 | 18 | 22,500,000 | I |
11 May 2023 21:11 | SLRN | ACELYRIN Inc | SVORONOS DAWN | Director | 09 May 2023 | Purchase | 15,000 | 18 | 270,000 | D |
11 May 2023 21:06 | SLRN | ACELYRIN Inc | GOSEBRUCH HENRY O | Director | 09 May 2023 | Purchase | 50,000 | 18 | 900,000 | D |
11 May 2023 21:02 | SLRN | ACELYRIN Inc | BECKER DANIEL J. | Director | 09 May 2023 | Purchase | 3,000 | 18 | 54,000 | D |
11 May 2023 21:00 | SLRN | ACELYRIN Inc | OYSTON RONALD | Chief People Officer | 09 May 2023 | Purchase | 26 | 18 | 468 | I |
11 May 2023 21:00 | SLRN | ACELYRIN Inc | OYSTON RONALD | Chief People Officer | 09 May 2023 | Purchase | 1,000 | 18 | 18,000 | D |
11 May 2023 20:58 | SLRN | ACELYRIN Inc | KIM MINA | Chief Legal & Admin. Officer | 09 May 2023 | Purchase | 5,000 | 18 | 90,000 | D |
11 May 2023 20:54 | SLRN | ACELYRIN Inc | PELOSO PAUL | Chief Medical Officer | 09 May 2023 | Purchase | 6,000 | 18 | 108,000 | D |
11 May 2023 20:51 | SLRN | ACELYRIN Inc | DIER MARDI | CFO and CBO | 09 May 2023 | Purchase | 875 | 18 | 15,750 | I |
11 May 2023 20:51 | SLRN | ACELYRIN Inc | DIER MARDI | CFO and CBO | 09 May 2023 | Purchase | 875 | 18 | 15,750 | I |
11 May 2023 20:51 | SLRN | ACELYRIN Inc | DIER MARDI | CFO and CBO | 09 May 2023 | Purchase | 5,556 | 18 | 100,008 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)